Amer Zeidan/LinkedIn
Sep 6, 2026, 10:51
Amer Zeidan: Looking Ahead to ESH MDS 2026 in Ireland
Amer Zeidan, Chief of Division of Hematologic Malignancies at Yale Comprehensive Cancer Center, Professor of Medicine, Medical Oncology and Hematology at Yale University, shared a post on LinkedIn:
“Looking forward to this excellent meeting on MDS by the European School of Haematology ESH MDS 2026 in Ireland and hope to meet many of you there…”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 02:00How Antiphospholipid Syndrome Can Affect the Adrenal Glands – APS Foundation of America
-
Oct 17, 2026, 01:59Liza-Marie Johnson: How Far Should Clinicians Go to Influence Parents’ Decisions?
-
Oct 17, 2026, 01:54Jim Hoffman: The Importance of Self-Advocacy and Understanding Autoimmune Mechanisms
-
Oct 17, 2026, 01:53Kristopher Jonas: Listening to Patients and Recognizing the Donors Who Make Treatment Possible
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting
-
Oct 16, 2026, 17:50Elad Asher։ STORM-PE Shows Functional Benefits of Thrombectomy
-
Oct 16, 2026, 17:32Shruthi Narayan: STORM-PE and STRIKE-PE Studies Advance Understanding of Recovery After Pulmonary Embolism
-
Oct 16, 2026, 17:22Wolfgang Miesbach։ What a Near-Perfect FISH Score Fails to See
-
Oct 16, 2026, 17:06Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke